GALECTIN THERAPEUTICS INC — Director's Dealing 2019

Jun 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2019-05-31

Reporting Person: ELDRED KARY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-31	Common Stock	P	3033	$4.28	Acquired	44415	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-31	Common Stock Purchase Warrant (right to buy)	$7.00	P	10110	Acquired	2026-05-31	Common stock (758)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2425	Indirect
Common Stock	2000	Indirect

Footnotes

F1: These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.

F2: These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: Each warrant is exerciseable for 0.075 shares of Common Stock of the Company.